Literature DB >> 760888

Pharmacological properties of kryptopyrrole and its oxidation products on isolated sciatic nerve of rat and on guinea-pig ileum.

A Gorchein, L D Mitchell, A T Rogers.   

Abstract

1 Kryptopyrrole (2, 4-dimethyl, 3-ethylpyrrole) inhibited conduction in rat sciatic nerve by a local anaesthetic action. 2 Tone and both spontaneous and electrically-induced contractions of guinea-pig ileum were also inhibited by kryptopyrrole. The concentration of kryptopyrrole required for 50% inhibition of a maximum twitch tension (ID50) was 0.085 mM. 3 Oxidation products of kryptopyrrole with chromatographic properties similar to those of urinary constituents reported in schizophrenia and hepatic porphyrias had little or no effect at similar concentrations. 4 Dose-response curves to exogenous acetylcholine in guinea-pig ileum were shifted to the right by kryptopyrrole, with loss of parallelism and reduction in the maximum contraction. 5 Acetylcholine overflow from ileal segments at rest and during electrical stimulation was reduced by kryptopyrrole. 6 These results on ileal segments are consistent with kryptopyrrole having both a post-junctional site of action, presumably directly on the muscle, and a pre-junctional site reducing the output of acetylcholine from the myenteric plexus. 7 The significance of these findings is discussed in relation to a possible clinical pathological role for these compounds.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760888      PMCID: PMC1668463          DOI: 10.1111/j.1476-5381.1979.tb17329.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  MALVARIA: A NEW PSYCHIATRIC DISEASE.

Authors:  A Hoffer; H Osmond
Journal:  Acta Psychiatr Scand       Date:  1963       Impact factor: 6.392

2.  Apparently non-indolic Ehrlich-positive substances related to mental illnesses.

Authors:  D G IRVINE
Journal:  J Neuropsychiatr       Date:  1961-08

3.  Porphobilinogen.

Authors:  G H COOKSON; C RIMINGTON
Journal:  Biochem J       Date:  1954-07       Impact factor: 3.857

4.  Kryptopyrrole-like substance in acute intermittent porphyria.

Authors:  D G Irvine; L Wetterberg
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

5.  Experimental data to the pathogenesis of cryptopyrrole excretion in schizophrenia, I.

Authors:  I Huszák; I Durkó; K Karsai
Journal:  Acta Physiol Acad Sci Hung       Date:  1972

6.  The dye sensitized photooxygenation of kryptopyrrole.

Authors:  D A Lightner; D C Crandall
Journal:  Experientia       Date:  1973-03-15

7.  Pharmacological and toxic effects of kryptopyrrole in mice.

Authors:  L Wetterberg
Journal:  Ups J Med Sci       Date:  1973       Impact factor: 2.384

8.  Magnesium protoporphyrin chelatase activity in Rhodopseudomonas spheroides. Studies with whole cells.

Authors:  A Gorchein
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

9.  The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip.

Authors:  W D Paton; E S Vizi
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

10.  The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips.

Authors:  W D Paton; M A Zar
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

View more
  1 in total

1.  The 'mauve factor' of schizophrenia and porphyria, 5-hydroxyhaemopyrrole lactam, has low pharmacological potency on guinea-pig ileum.

Authors:  A Gorchein; A T Rogers
Journal:  Experientia       Date:  1979-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.